NioCorp Developments is trading at $0.55, up 3.08%; Traxys is a plausible catalyst, but supplied market data do not establish causation. - Announced October 13, 2026, the binding 15-year Traxys agreement covers half of planned ferroniobium production; the existing ThyssenKrupp agreement covers the other half, together supporting commercial sales coverage for all planned Elk Creek production. - Traxys has exclusive marketing and sales rights for planned scandium, titanium, and rare-earth products; deliveries depend on project financing, construction, and production.